Karizoo
Flunixin 50 mg/ml solution for injection for cattle, horses and pigs 100 ml

Alleviation of inflammation and pain associated with musculo-skeletal and respiratory disease for cattle, horses and pigs

Some countries require a prescription to be issued for the sale of this drug.

Flunixin 50 mg/ml is a clear colourless solution for injection for:

  • Horses: The lleviation of inflammation and pain associated with musculo-skeletal disorders and for the alleviation of visceral pain associated with colic, also indicated for the treatment of endotoxaemia or septic shock associated with gastric torsion and for other conditions in which the circulation of the blood to the gastrointestinal tract is compromised.
  • Cattle: The control of acute inflammation associated with respiratory disease. It may also be used as adjunctive therapy in the treatment of acute mastitis.
  • Pigs: To use as an adjunctive therapy in the treatment of swine respiratory diseases.

Each ml of Flunixin 50 mg/ml contains:

Active substance:

  • Flunixin (as flunixin meglumine) 50 mg

Excipients:

  • Phenol 5.0 mg
  • Sodium Formaldehyde Sulphoxylate Dihydrate 2.5 mg
  • Disodium Edetate
  • Propylene Glycol
  • Diethanolamine
  • Hydrochloric Acid
  • Water for Injections

Flunixin 50 mg/ml:

  • Do not exceed the recommended dose or the duration of treatment.
  • Do not administer to pregnant mares.
  • Do not administer to pregnant sows, gilts at mating and in breeding boars.
  • Use is contraindicated in animals suffering from cardiac, hepatic or renal disease, where there is the possibility of gastro-intestinal ulceration or bleeding, where there is evidence of a blood dyscrasia or hypersensitivity to the product.
  • Do not use in dehydrated animals suffering from ileus-associated colics.
  • Do not use the product within 48 hours before expected parturition in cows.

Withdrawal periods:

  • Cattle:
    • Meat & offal: 7 days
    • Milk: 36 hours
  • Horses:
    • Meat & offal: 7 days
  • Pigs:
    • Meat & offal: 22 days
  • Do not use in mares producing milk for human consumption.

Flunixin 50 mg/ml posology:

  • For intravenous administration to cattle and horses and intramuscular injection to pigs.
  • Horses:
    • For use in equine colic, the recommended dose rate is 1.1 mg flunixin/kg bodyweight equivalent to 1 ml per 45 kg bodyweight. Treatment may be repeated once or twice if colic recurs.
    • For use in musculo-skeletal disorders, the recommended dose rate is 1.1 mg flunixin/kg bodyweight equivalent to 1 ml per 45 kg bodyweight, once daily for up to 5 days according to clinical response.
    • For the treatment of endotoxaemia or septic shock associated with gastric torsion and with other conditions in which the circulation of blood to the gastrointestinal tract is compromised: 0.25 mg/kg (1 ml per 200 kg) every 6-8 hours.
  • Cattle:
    • The recommended dose rate is 2.2 mg flunixin/kg bodyweight equivalent to 2 ml per 45 kg bodyweight. Repeat as necessary at 24 hour intervals for up to 5 consecutive days.
  • Pigs:
    • For use in pigs, the recommended dose rate is 2 ml per 45 kg bodyweight (equivalent to 2.2 mg flunixin/kg) once by intramuscular injection, in the neck, in conjunction with appropriate antimicrobial therapy. The injection volume should be limited to a maximum of 5ml per injection site.
  • The stopper should not be punctured more than 50 times. A draw off needle should be used to avoid excessive puncturing of the stopper.
  • Do not exceed the recommended dose or duration of treatment.
  • An appropriately graduated syringe must be used to allow accurate administration of the required dose volume. This is particularly important when injecting small volumes.

Flunixin 50 mg/ml is a clear colourless solution for injection for:

  • Horses: The lleviation of inflammation and pain associated with musculo-skeletal disorders and for the alleviation of visceral pain associated with colic, also indicated for the treatment of endotoxaemia or septic shock associated with gastric torsion and for other conditions in which the circulation of the blood to the gastrointestinal tract is compromised.
  • Cattle: The control of acute inflammation associated with respiratory disease. It may also be used as adjunctive therapy in the treatment of acute mastitis.
  • Pigs: To use as an adjunctive therapy in the treatment of swine respiratory diseases.

Each ml of Flunixin 50 mg/ml contains:

Active substance:

  • Flunixin (as flunixin meglumine) 50 mg

Excipients:

  • Phenol 5.0 mg
  • Sodium Formaldehyde Sulphoxylate Dihydrate 2.5 mg
  • Disodium Edetate
  • Propylene Glycol
  • Diethanolamine
  • Hydrochloric Acid
  • Water for Injections

Flunixin 50 mg/ml:

  • Do not exceed the recommended dose or the duration of treatment.
  • Do not administer to pregnant mares.
  • Do not administer to pregnant sows, gilts at mating and in breeding boars.
  • Use is contraindicated in animals suffering from cardiac, hepatic or renal disease, where there is the possibility of gastro-intestinal ulceration or bleeding, where there is evidence of a blood dyscrasia or hypersensitivity to the product.
  • Do not use in dehydrated animals suffering from ileus-associated colics.
  • Do not use the product within 48 hours before expected parturition in cows.

Withdrawal periods:

  • Cattle:
    • Meat & offal: 7 days
    • Milk: 36 hours
  • Horses:
    • Meat & offal: 7 days
  • Pigs:
    • Meat & offal: 22 days
  • Do not use in mares producing milk for human consumption.

Flunixin 50 mg/ml posology:

  • For intravenous administration to cattle and horses and intramuscular injection to pigs.
  • Horses:
    • For use in equine colic, the recommended dose rate is 1.1 mg flunixin/kg bodyweight equivalent to 1 ml per 45 kg bodyweight. Treatment may be repeated once or twice if colic recurs.
    • For use in musculo-skeletal disorders, the recommended dose rate is 1.1 mg flunixin/kg bodyweight equivalent to 1 ml per 45 kg bodyweight, once daily for up to 5 days according to clinical response.
    • For the treatment of endotoxaemia or septic shock associated with gastric torsion and with other conditions in which the circulation of blood to the gastrointestinal tract is compromised: 0.25 mg/kg (1 ml per 200 kg) every 6-8 hours.
  • Cattle:
    • The recommended dose rate is 2.2 mg flunixin/kg bodyweight equivalent to 2 ml per 45 kg bodyweight. Repeat as necessary at 24 hour intervals for up to 5 consecutive days.
  • Pigs:
    • For use in pigs, the recommended dose rate is 2 ml per 45 kg bodyweight (equivalent to 2.2 mg flunixin/kg) once by intramuscular injection, in the neck, in conjunction with appropriate antimicrobial therapy. The injection volume should be limited to a maximum of 5ml per injection site.
  • The stopper should not be punctured more than 50 times. A draw off needle should be used to avoid excessive puncturing of the stopper.
  • Do not exceed the recommended dose or duration of treatment.
  • An appropriately graduated syringe must be used to allow accurate administration of the required dose volume. This is particularly important when injecting small volumes.
24.30
Order within 10h 1m 4s (before 12AM)
And receive your order
on Monday 23 October
AIR FREIGHT

Customers who buy this product, usually buy: